Celsius®Driver Blake Koch Will Open The 2014 Season Driving Award Winning Mark Burnett and Roma Downey's "Son Of God" Car At Daytona On February 22nd

Boca Raton, FL (February 17, 2014) – Celsius Holdings, Inc., (Other OTC: CELH) the creator and marketer of Celsius®, the world’s first and only Negative Calorie beverage backed by clinical science, is excited to announce the partnership with NASCAR driver Blake Koch for the 2014 Nationwide Series.                                         

“We are excited to partner with Blake Koch, who exemplifies the competitiveness, athleticism and quality of life that the Celsius brand is recognized for," stated Gerry David, CEO, Celsius Holdings.  David continued, "Our partnership with Blake, provides Celsius the opportunity to reach the 70+ million avid NASCAR fans with a healthy alternative to the traditional energy drinks being consumed.  Blake's passion for competing is also seen off the track in his Ironman and Tri-Athlete competitions.

Koch stated, "I first heard about Celsius back in 2009 and have been a fan ever since. I am so proud to team up with Celsius, a growing brand and to promote something I truly believe in. I start every day off with a Celsius, race day or triathlon training day, it helps me accomplish my goals."

About Blake Koch

Blake Koch has created a major fan base in both the NASCAR community and the faith based market over the past five years. In 2009, with only 20 amateur races under his belt, he was recruited by Steve Portenga to join as the primary driver for the Richard Childress Driver development team in the NASCAR Camping World West Division. Blake achieved an impressive top ten finish in his rookie year by finishing the season eighth in points.

2014 has started a new chapter for Koch; as he has signed on to drive full-time for TriStar Motorsports bouncing between the No. 10 and 44 Toyota Camry in the NASCAR Nationwide Series. Koch will join NASCAR veterans Eric McClure and Mike Bliss in the TriStar Motorsports stable.

About Celsius Holdings, Inc.:

Celsius Holding, Inc. (Other OTC: CELH) markets Celsius®, which is backed by published clinical studies. Celsius is dedicated to providing healthier, everyday refreshment through science and innovation. For more information please visit, www.celsius.com

Forward-Looking Statements:

This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings’ future results of operations and/or financial position, or state other forward-looking information. In some cases you can identify these statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expert,” “intend,” “may,” “should,” “will,” “would,” or similar words. You should not rely on forward-looking statements since Celsius Holdings’ actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include, but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business; and other risks and uncertainties discussed in the reports Celsius Holdings has filed previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release.

Celsius Contact:

John Fieldly, CFO, (866) 4-CELSIUS, (561) 276-2239, jfieldly@celsius.com

Media Contact:

Jacqueline De Berry, 5W Public Relations, (646) 452-6417, jdeberry@5wpr.com


Print Friendly
 © 2017 Celsius. All rights reserved.

†CELSIUS alone does not produce weight loss in the absence of a healthy diet and moderate exercise. So, whether you walk the dog or work out at the gym, make CELSIUS part of your daily regimen.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. PRIVACY POLICY | CONTACT

Follow us: